622 related articles for article (PubMed ID: 16267497)
21. Improving global virologic surveillance for measles and rubella.
Rota PA; Brown KE; Hübschen JM; Muller CP; Icenogle J; Chen MH; Bankamp B; Kessler JR; Brown DW; Bellini WJ; Featherstone D
J Infect Dis; 2011 Jul; 204 Suppl 1():S506-13. PubMed ID: 21666207
[TBL] [Abstract][Full Text] [Related]
22. Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009.
Reef SE; Strebel P; Dabbagh A; Gacic-Dobo M; Cochi S
J Infect Dis; 2011 Jul; 204 Suppl 1():S24-7. PubMed ID: 21666168
[TBL] [Abstract][Full Text] [Related]
23. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
[TBL] [Abstract][Full Text] [Related]
24. Status of global virologic surveillance for rubella viruses.
Abernathy ES; Hübschen JM; Muller CP; Jin L; Brown D; Komase K; Mori Y; Xu W; Zhu Z; Siqueira MM; Shulga S; Tikhonova N; Pattamadilok S; Incomserb P; Smit SB; Akoua-Koffi C; Bwogi J; Lim WW; Woo GK; Triki H; Jee Y; Mulders MN; de Filippis AM; Ahmed H; Ramamurty N; Featherstone D; Icenogle JP
J Infect Dis; 2011 Jul; 204 Suppl 1():S524-32. PubMed ID: 21666209
[TBL] [Abstract][Full Text] [Related]
25. Global distribution of measles genotypes and measles molecular epidemiology.
Rota PA; Brown K; Mankertz A; Santibanez S; Shulga S; Muller CP; Hübschen JM; Siqueira M; Beirnes J; Ahmed H; Triki H; Al-Busaidy S; Dosseh A; Byabamazima C; Smit S; Akoua-Koffi C; Bwogi J; Bukenya H; Wairagkar N; Ramamurty N; Incomserb P; Pattamadilok S; Jee Y; Lim W; Xu W; Komase K; Takeda M; Tran T; Castillo-Solorzano C; Chenoweth P; Brown D; Mulders MN; Bellini WJ; Featherstone D
J Infect Dis; 2011 Jul; 204 Suppl 1():S514-23. PubMed ID: 21666208
[TBL] [Abstract][Full Text] [Related]
26. Enhanced laboratory surveillance for the elimination of rubella and congenital rubella syndrome in the Americas.
Bispo de Filippis AM; Icenogle J; Matus CR; Andrus JK
J Infect Dis; 2011 Sep; 204 Suppl 2():S652-8. PubMed ID: 21954262
[TBL] [Abstract][Full Text] [Related]
27. Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
O'Connor P; Jankovic D; Zimmerman L; Ben Mamou M; Reef S
MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):833-839. PubMed ID: 34111057
[TBL] [Abstract][Full Text] [Related]
28. Measles and rubella in the World Health Organization European region: diversity creates challenges.
Spika JS; Wassilak S; Pebody R; Lipskaya G; Deshevoi S; Guris D; Emiroglu N
J Infect Dis; 2003 May; 187 Suppl 1():S191-7. PubMed ID: 12721913
[TBL] [Abstract][Full Text] [Related]
29. Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.
Brown KE; Rota PA; Goodson JL; Williams D; Abernathy E; Takeda M; Mulders MN
MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(26):587-591. PubMed ID: 31269012
[TBL] [Abstract][Full Text] [Related]
30. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
Best JM; Castillo-Solorzano C; Spika JS; Icenogle J; Glasser JW; Gay NJ; Andrus J; Arvin AM
J Infect Dis; 2005 Dec; 192(11):1890-7. PubMed ID: 16267759
[TBL] [Abstract][Full Text] [Related]
31. Global use of rubella vaccines, 1980-2009.
Strebel PM; Gacic-Dobo M; Reef S; Cochi SL
J Infect Dis; 2011 Sep; 204 Suppl 2():S579-84. PubMed ID: 21954250
[TBL] [Abstract][Full Text] [Related]
32. The Measles Laboratory Network in the region of the Americas.
Venczel L; Rota J; Dietz V; Morris-Glasgow V; Siqueira M; Quirogz E; Rey G; de Quadros C
J Infect Dis; 2003 May; 187 Suppl 1():S140-5. PubMed ID: 12721905
[TBL] [Abstract][Full Text] [Related]
33. Progress in measles control--Nepal, 2000-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(39):1028-31. PubMed ID: 17914331
[TBL] [Abstract][Full Text] [Related]
34. Global measles elimination efforts: the significance of measles elimination in the United States.
Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
[TBL] [Abstract][Full Text] [Related]
35. Measles and rubella eradication in the Americas.
Andrus JK; de Quadros CA; Solórzano CC; Periago MR; Henderson DA
Vaccine; 2011 Dec; 29 Suppl 4():D91-6. PubMed ID: 22185837
[TBL] [Abstract][Full Text] [Related]
36. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
37. Progress toward measles and rubella elimination in Egypt.
El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE
J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
[TBL] [Abstract][Full Text] [Related]
38. Global measles mortality, 2000-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(47):1321-6. PubMed ID: 19959985
[TBL] [Abstract][Full Text] [Related]
39. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1176-9. PubMed ID: 18971920
[TBL] [Abstract][Full Text] [Related]
40. Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas.
Castillo-Solórzano C; Reef SE; Morice A; Andrus JK; Ruiz Matus C; Tambini G; Gross-Galiano S
J Infect Dis; 2011 Sep; 204 Suppl 2():S683-9. PubMed ID: 21954267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
